Zobrazeno 1 - 10 of 151 pro vyhledávání: '"Krisztina Gecse"'
1
Akademický článek
Clinical relevance of endoscopic peri-appendiceal red patch in ulcerative colitis patients
Autor: Maud A. Reijntjes, Lianne Heuthorst, Krisztina Gecse, Aart Mookhoek, Willem A. Bemelman, Christianne J. Buskens
Publikováno v: Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: Increasing evidence is suggesting appendectomy as an alternative treatment for ulcerative colitis (UC), especially in case of histological appendiceal inflammation. Therefore, preoperative identification of appendiceal inflammation could
Externí odkaz: https://doaj.org/article/4a131496a0d242e990187c745feed60f
Zobrazit plný text záznamu
2
Akademický článek
Validation Study of Novel Point-of-Care Tests for Infliximab, Adalimumab and C-Reactive Protein in Capillary Blood and Calprotectin in Faeces in an Ambulatory Inflammatory Bowel Disease Care Setting
Autor: Adriaan Volkers, Mark Löwenberg, Marlou Braad, Yara Abeling, Krisztina Gecse, Nicole Berkers, Nahid Montazeri, Geert D’Haens
Publikováno v: Diagnostics, Vol 13, Iss 10, p 1712 (2023)
Background and aims: Point-of-care tests (POCT) allow instant measurement of inflammatory markers and drug concentrations. Here, we studied agreement between a novel POCT device and reference methods of measuring infliximab (IFX) and adalimumab (ADL)
Externí odkaz: https://doaj.org/article/e6448056111e4d56bdf6bcebc9eaf899
Zobrazit plný text záznamu
3
A Narrative Systematic Review and Categorisation of Outcomes in Inflammatory Bowel Disease to Inform a Core Outcome Set for Real-world Evidence
Autor: Charlotte Wong, Joep van Oostrom, Peter Bossuyt, Valerie Pittet, Jurij Hanzel, Mark Samaan, Monika Tripathi, Wladyslawa Czuber-Dochan, Johan Burisch, Salvatore Leone, Roberto Saldaña, Filip Baert, Uri Kopylov, Susanna Jaghult, Michel Adamina, Krisztina Gecse, Naila Arebi
Publikováno v: Journal of Crohn's & colitis, 16(10), 1511-1522. Elsevier
Wong, C, Van oostrom, J, Bossuyt, P, Pittet, V, Hanzel, J, Samaan, M, Tripathi, M, Czuber-Dochan, W, Burisch, J, Leone, S, Saldaña, R, Baert, F, Kopylov, U, Jaghult, S, Adamina, M, Gecse, K & Arebi, N 2022, ' A Narrative Systematic Review and Categorisation of Outcomes in Inflammatory Bowel Disease to Inform a Core Outcome Set for Real-world Evidence ', Journal Of Crohns & Colitis, vol. 16, no. 10, pp. 1511-1522 . https://doi.org/10.1093/ecco-jcc/jjac057
Background Heterogeneity exists in reported outcomes and outcome measurement instruments [OMI] from observational studies. A core outcome set [COS] for observational and real-world evidence [RWE] in inflammatory bowel disease [IBD] will facilitate po
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6a42a16748e93353fc1b03756742cf3
https://doi.org/10.1093/ecco-jcc/jjac057
Zobrazit plný text záznamu
4
Development of a Core Outcome Set for Real-world Data in Inflammatory Bowel Disease: A European Crohn’s and Colitis Organisation [ECCO] Position Paper
Autor: Jurij Hanzel, Peter Bossuyt, Valerie Pittet, Mark Samaan, Monika Tripathi, Wladyslawa Czuber-Dochan, Johan Burisch, Salvatore Leone, Roberto Saldaña, Filip Baert, Uri Kopylov, Susanna Jäghult, Michel Adamina, Naila Arebi, Krisztina Gecse
Publikováno v: Journal of Crohn's & colitis, 17(3), 311-317. Elsevier
Background and Aims The utility of real-world data is dependent on the quality and homogeneity of reporting. We aimed to develop a core outcome set for real-world studies in adult patients with inflammatory bowel disease [IBD]. Methods Candidate outc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::283b389f33688adc3f3155dab0bbaff0
https://doi.org/10.1093/ecco-jcc/jjac136
Zobrazit plný text záznamu
5
Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program
Autor: Edward V Loftus, Daniel C Baumgart, Krisztina Gecse, Jami A Kinnucan, Susan B Connelly, Leonardo Salese, Chinyu Su, Kenneth K Kwok, John C Woolcott, Alessandro Armuzzi
Publikováno v: Inflammatory Bowel Diseases. 29:744-751
Background Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). Patients with inflammatory bowel disease are susceptible to Clostridium difficile infection (CDI). Here, we evaluate CDI in the tof
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1e25a450b042936eeff88a08da0d70a
https://doi.org/10.1093/ibd/izac139
Zobrazit plný text záznamu
6
Superior effectiveness of tofacitinib compared to vedolizumab in anti-TNF experienced ulcerative colitis patients: a nationwide Dutch Registry study
Autor: Tessa Straatmijer, Vince B.C. Biemans, Marijn Visschedijk, Frank Hoentjen, Annemarie de Vries, Adriaan A. van Bodegraven, Alexander Bodelier, Nanne K.H. de Boer, Gerard Dijkstra, Noortje Festen, Carmen Horjus, Jeroen M. Jansen, Bindia Jharap, Wout Mares, Fiona D.M. van Schaik, Cyriel Ponsioen, Tessa Romkens, Nidhi Srivastava, Michael M.P. J.A. van der Voorn, Rachel West, Janneke van der Woude, Marije D.J. Wolvers, Marieke Pierik, Andrea E. van der Meulen-de Jong, Marjolijn Duijvestein, Malena Schlotter, Martine van Workum, Dirk de Jong, Willemijn van Dop, S. van der Marel, Hayat El Ghabzouri, Kamila Talhaoui, Bas Oldenburg, Nynke Boontje, Herma Fidder, Meike Hirdes, Rob H. Creemers, J. Hoekstra, Jael Smid, Zlatan Mujagic, Marthe François-Verweij, Toos Schakel- van den Berge, Jeroen Maljaars, Rosaline Theeuwen, Denise van den Berg, Suzanne Gerretsen, Xenia Yocarini, Geert D’Haens, Mark Lowenberg, Joep Grootjans, Krisztina Gecse, Gerd Bouma, Petra Waaijenberg, Bart Muskens
Publikováno v: Clinical Gastroenterology and Hepatology, 21(1), 182-191.e2. ELSEVIER SCIENCE INC
Clinical Gastroenterology and Hepatology, 21, 1, pp. 182-191.e2
Clinical Gastroenterology and Hepatology, 21(1), 182-191.e2. W.B. Saunders Ltd
Clinical Gastroenterology and Hepatology, 21, 182-191.e2
Clinical gastroenterology and hepatology. Elsevier Science
Clinical gastroenterology and hepatology, 21(1), 182-191.e2. W.B. Saunders Ltd
Initiative on Crohn and Colitis 2023, ' Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients : A Nationwide Dutch Registry Study ', Clinical Gastroenterology and Hepatology, vol. 21, no. 1, pp. 182-191.e2 . https://doi.org/10.1016/j.cgh.2022.04.038
Clinical Gastroenterology and Hepatology, 21(1), 182-191.e2. W.B. Saunders
Background & Aims: Clinicians face difficulty in when and in what order to position biologics and Janus kinase inhibitors in patients with anti-tumor necrosis factor-alpha (TNF) refractory ulcerative colitis (UC). We aimed to compare the effectivenes
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16c5fd40e67e975df5ce34fd01d6aa67
https://research.rug.nl/en/publications/4d7e144b-6332-47f9-9cee-542a2092238d
Zobrazit plný text záznamu
7
Work productivity loss is determined by fatigue and reduced quality of life in employed inflammatory bowel disease patients
Autor: Cyriel Y. Ponsioen, Svend T. Rietdijk, Marjolijn Duijvestein, Mark Löwenberg, Krisztina Gecse, Angela G. E. M. de Boer, Sara van Gennep, Geert R. D'Haens, Nanne K. H. de Boer, Marieke E Gielen
Publikováno v: van Gennep, S, Gielen, M E, Rietdijk, S T, de Boer, N K H, Duijvestein, M, Gecse, K B, Ponsioen, C Y, D'Haens, G R, de Boer, A G E M & Löwenberg, M 2021, ' Work productivity loss is determined by fatigue and reduced quality of life in employed inflammatory bowel disease patients : a prospective multicentre cohort study ', European journal of gastroenterology & hepatology, vol. 33, no. 1S Suppl 1, pp. e594-e602 . https://doi.org/10.1097/MEG.0000000000002178
European journal of gastroenterology & hepatology, 33(1S Suppl 1), e594-e602. Lippincott Williams and Wilkins
OBJECTIVE: Inflammatory bowel disease (IBD) patients experience problems at work resulting in work productivity loss driving indirect healthcare costs. We aimed to find determinants for work productivity loss in employed IBD patients while correcting
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73053a3bfd09a2abf8c2fa530de1c100
https://doi.org/10.1097/meg.0000000000002178
Zobrazit plný text záznamu
9
The knowledge and skills needed to perform intestinal ultrasound for inflammatory bowel diseases-an international Delphi consensus survey
Autor: Gorm Roager Madsen, Rune Wilkens, Trine Boysen, Johan Burisch, Robert Bryant, Dan Carter, Krisztina Gecse, Christian Maaser, Giovanni Maconi, Kerri Novak, Carolina Palmela, Leizl Joy Nayahangan, Martin Grønnebæk Tolsgaard
Publikováno v: Madsen, G R, Wilkens, R, Boysen, T, Burisch, J, Bryant, R, Carter, D, Gecse, K, Maaser, C, Maconi, G, Novak, K, Palmela, C, Nayahangan, L J & Tolsgaard, MG 2022, ' The knowledge and skills needed to perform intestinal ultrasound for inflammatory bowel diseases — an international Delphi consensus survey ', Alimentary Pharmacology and Therapeutics, vol. 56, no. 2, pp. 263-270 . https://doi.org/10.1111/apt.16950
Alimentary Pharmacology and Therapeutics, 56(2), 263-270. Wiley-Blackwell
Background: Intestinal ultrasound (IUS) is a non-invasive modality for monitoring disease activity in inflammatory bowel diseases (IBD). IUS training currently lacks well-defined standards and international consensus on competency criteria. Aim: To a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ea400e6571ba2044bec3500666c0a3e
https://pubmed.ncbi.nlm.nih.gov/35748831
Zobrazit plný text záznamu
10
Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn's disease; the Sensitivity to Change (STOC) study
Autor: Adriaan Volkers, Peter Bossuyt, Jitteke de Jong, Lieven Pouillon, Krisztina Gecse, Marjolijn Duijvestein, Cyriel Ponsioen, Geert D’Haens, Mark Löwenberg
Publikováno v: Scandinavian journal of gastroenterology. Informa Healthcare
Scandinavian Journal of Gastroenterology, 57(4), 439-445. Informa Healthcare
Scandinavian Journal of Gastroenterology, 57, 439-445
Scandinavian Journal of Gastroenterology, 57, 4, pp. 439-445
Contains fulltext : 252134.pdf (Publisher’s version ) (Closed access) BACKGROUND: The potential use of pan-enteric capsule endoscopy (pan-CE) to evaluate mucosal changes during treatment has not been evaluated. We aimed to assess the ability of pan
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bab67454ed28b12eee9db5ac9d6d6e23
https://doi.org/10.1080/00365521.2021.2018491
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje